Arcadia Biosciences (RKDA) Misses Q4 EPS by 12c

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.42), $0.12 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.17 million versus the consensus estimate of $3.33 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Carter's (CRI) Tops Q1 EPS by 29c
• Autoliv (ALV) Tops Q1 EPS by 14c